Juniper Biologics signs exclusive license agreement with Helsinn for infigratinib (INN) for the emerging markets including India
Infigratinib is not FDA-, Health Canada- or Therapeutics Goods Association-approved for any other indication
Infigratinib is not FDA-, Health Canada- or Therapeutics Goods Association-approved for any other indication
The procedures have been performed by Dr. Kaushal Pandey at P.D. Hinduja Hospital in Mumbai, India
This RT-PCR diagnostic kit helps in diagnosis of AS by detecting HLAB27 gene
The facility is among 12 centres established worldwide, and the first in Asia
The announcement follows FDA 510(k) clearance of device
CIVCO RT will also display its recent innovations focusing on improving patient comfort and outcomes
As an industrial partner of the IHU, the Medi-Globe Group is thus further expanding its role as an innovation leader in minimally invasive diagnostics and therapies
Blood test for early detection of Alzheimer's Disease (AD) risk will lead to better patient care, physicians say; US. adults call for earlier evaluation and more education
The planned Phase 1 study is a double-blind, randomized, placebo-controlled dose-escalation study in healthy adult subjects and AD patients
The USFDA approval in AS marks the fifth indication for Rinvoq in chronic immune-mediated diseases
Subscribe To Our Newsletter & Stay Updated